STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 35.83 Million USD | 15.45% |
| 2022 | 31.03 Million USD | -3.19% |
| 2021 | 32.06 Million USD | 196.89% |
| 2020 | 10.79 Million USD | 13.21% |
| 2019 | 9.53 Million USD | 78.73% |
| 2018 | 5.33 Million USD | -14.57% |
| 2017 | 6.24 Million USD | -8.4% |
| 2016 | 6.82 Million USD | 44.34% |
| 2015 | 4.72 Million USD | -5.82% |
| 2014 | 5.01 Million USD | -3.13% |
| 2013 | 5.17 Million USD | -27.74% |
| 2012 | 7.16 Million USD | 66.64% |
| 2011 | 4.3 Million USD | 0.16% |
| 2010 | 4.29 Million USD | -49.81% |
| 2009 | 8.55 Million USD | -4.27% |
| 2008 | 8.93 Million USD | 41.9% |
| 2007 | 6.29 Million USD | 93.28% |
| 2006 | 3.25 Million USD | 94.45% |
| 2005 | 1.67 Million USD | -44.21% |
| 2004 | 3 Million USD | 1.83% |
| 2003 | 2.95 Million USD | -49.53% |
| 2002 | 5.84 Million USD | -28.86% |
| 2001 | 8.21 Million USD | 3.42% |
| 2000 | 7.94 Million USD | -51.56% |
| 1999 | 16.4 Million USD | 33.33% |
| 1998 | 12.3 Million USD | 66.22% |
| 1997 | 7.4 Million USD | -17.78% |
| 1996 | 9 Million USD | 73.08% |
| 1995 | 5.2 Million USD | 116.67% |
| 1994 | 2.4 Million USD | 50.0% |
| 1993 | 1.6 Million USD | 166.67% |
| 1992 | 600 Thousand USD | -45.45% |
| 1991 | 1.1 Million USD | -54.17% |
| 1990 | 2.4 Million USD | -79.49% |
| 1989 | 11.7 Million USD | 18.18% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 40 Million USD | 10.28% |
| 2024 Q2 | 36.27 Million USD | 1.62% |
| 2024 Q1 | 35.69 Million USD | -0.39% |
| 2023 Q4 | 35.83 Million USD | -0.17% |
| 2023 FY | 35.83 Million USD | 15.45% |
| 2023 Q3 | 35.89 Million USD | 10.48% |
| 2023 Q2 | 32.48 Million USD | 1.83% |
| 2023 Q1 | 31.9 Million USD | 2.79% |
| 2022 Q3 | 29.92 Million USD | -3.62% |
| 2022 Q2 | 31.04 Million USD | -2.54% |
| 2022 Q4 | 31.03 Million USD | 3.72% |
| 2022 Q1 | 31.85 Million USD | -0.63% |
| 2022 FY | 31.03 Million USD | -3.19% |
| 2021 Q4 | 32.06 Million USD | 36.8% |
| 2021 FY | 32.06 Million USD | 196.89% |
| 2021 Q1 | 10.12 Million USD | -6.2% |
| 2021 Q2 | 12.8 Million USD | 26.46% |
| 2021 Q3 | 23.43 Million USD | 82.97% |
| 2020 FY | 10.79 Million USD | 13.21% |
| 2020 Q4 | 10.79 Million USD | 12.09% |
| 2020 Q3 | 9.63 Million USD | 26.75% |
| 2020 Q2 | 7.6 Million USD | -6.71% |
| 2020 Q1 | 8.14 Million USD | -14.58% |
| 2019 Q4 | 9.53 Million USD | -7.88% |
| 2019 FY | 9.53 Million USD | 78.73% |
| 2019 Q2 | 11.74 Million USD | -0.94% |
| 2019 Q3 | 10.35 Million USD | -11.8% |
| 2019 Q1 | 11.85 Million USD | 122.05% |
| 2018 Q4 | 5.33 Million USD | -13.68% |
| 2018 Q1 | 7.75 Million USD | 24.14% |
| 2018 FY | 5.33 Million USD | -14.57% |
| 2018 Q2 | 6.98 Million USD | -9.94% |
| 2018 Q3 | 6.18 Million USD | -11.47% |
| 2017 Q1 | 7.19 Million USD | 5.47% |
| 2017 Q2 | 6.84 Million USD | -4.91% |
| 2017 Q3 | 6.54 Million USD | -4.31% |
| 2017 FY | 6.24 Million USD | -8.4% |
| 2017 Q4 | 6.24 Million USD | -4.55% |
| 2016 FY | 6.82 Million USD | 44.34% |
| 2016 Q3 | 7.01 Million USD | 6.35% |
| 2016 Q2 | 6.59 Million USD | 33.44% |
| 2016 Q1 | 4.94 Million USD | 4.61% |
| 2016 Q4 | 6.82 Million USD | -2.78% |
| 2015 Q4 | 4.72 Million USD | -0.06% |
| 2015 FY | 4.72 Million USD | -5.82% |
| 2015 Q1 | 4.93 Million USD | -1.71% |
| 2015 Q2 | 4.7 Million USD | -4.5% |
| 2015 Q3 | 4.72 Million USD | 0.4% |
| 2014 Q2 | 5.97 Million USD | 15.24% |
| 2014 Q1 | 5.18 Million USD | 0.1% |
| 2014 FY | 5.01 Million USD | -3.13% |
| 2014 Q4 | 5.01 Million USD | -9.72% |
| 2014 Q3 | 5.55 Million USD | -6.98% |
| 2013 Q3 | 5.65 Million USD | -4.19% |
| 2013 Q1 | 6.34 Million USD | -11.44% |
| 2013 FY | 5.17 Million USD | -27.74% |
| 2013 Q4 | 5.17 Million USD | -8.4% |
| 2013 Q2 | 5.9 Million USD | -7.03% |
| 2012 Q2 | 4.1 Million USD | 1.96% |
| 2012 Q3 | 4.04 Million USD | -1.39% |
| 2012 Q4 | 7.16 Million USD | 77.09% |
| 2012 FY | 7.16 Million USD | 66.64% |
| 2012 Q1 | 4.02 Million USD | -6.42% |
| 2011 FY | 4.3 Million USD | 0.16% |
| 2011 Q3 | 4.18 Million USD | -0.81% |
| 2011 Q2 | 4.21 Million USD | 1.25% |
| 2011 Q1 | 4.16 Million USD | -3.07% |
| 2011 Q4 | 4.3 Million USD | 2.89% |
| 2010 FY | 4.29 Million USD | -49.81% |
| 2010 Q4 | 4.29 Million USD | 2.21% |
| 2010 Q1 | 8.05 Million USD | -5.82% |
| 2010 Q2 | 3.41 Million USD | -57.67% |
| 2010 Q3 | 4.2 Million USD | 23.16% |
| 2009 Q1 | 8.75 Million USD | -2.0% |
| 2009 Q2 | 9.2 Million USD | 5.13% |
| 2009 FY | 8.55 Million USD | -4.27% |
| 2009 Q4 | 8.55 Million USD | -0.89% |
| 2009 Q3 | 8.63 Million USD | -6.24% |
| 2008 Q2 | 8.37 Million USD | 32.52% |
| 2008 Q1 | 6.32 Million USD | 0.38% |
| 2008 FY | 8.93 Million USD | 41.9% |
| 2008 Q4 | 8.93 Million USD | 7.61% |
| 2008 Q3 | 8.3 Million USD | -0.87% |
| 2007 Q1 | 8.12 Million USD | 149.22% |
| 2007 FY | 6.29 Million USD | 93.28% |
| 2007 Q4 | 6.29 Million USD | 191.08% |
| 2007 Q3 | 2.16 Million USD | -1.73% |
| 2007 Q2 | 2.2 Million USD | -72.89% |
| 2006 FY | 3.25 Million USD | 94.45% |
| 2006 Q3 | 1.76 Million USD | -1.06% |
| 2006 Q4 | 3.25 Million USD | 84.44% |
| 2006 Q2 | 1.78 Million USD | 5.93% |
| 2006 Q1 | 1.68 Million USD | 0.6% |
| 2005 Q3 | 1.7 Million USD | -0.82% |
| 2005 Q1 | 1.83 Million USD | -38.78% |
| 2005 FY | 1.67 Million USD | -44.21% |
| 2005 Q2 | 1.71 Million USD | -6.69% |
| 2005 Q4 | 1.67 Million USD | -1.53% |
| 2004 Q4 | 3 Million USD | 8.88% |
| 2004 FY | 3 Million USD | 1.83% |
| 2004 Q1 | 2.98 Million USD | 1.05% |
| 2004 Q2 | 2.96 Million USD | -0.64% |
| 2004 Q3 | 2.75 Million USD | -6.85% |
| 2003 FY | 2.95 Million USD | -49.53% |
| 2003 Q4 | 2.95 Million USD | -9.43% |
| 2003 Q3 | 3.25 Million USD | 6.33% |
| 2003 Q2 | 3.06 Million USD | -41.61% |
| 2003 Q1 | 5.24 Million USD | -10.25% |
| 2002 Q3 | 6.35 Million USD | -22.58% |
| 2002 Q2 | 8.21 Million USD | 5.68% |
| 2002 Q1 | 7.76 Million USD | -5.44% |
| 2002 Q4 | 5.84 Million USD | -8.04% |
| 2002 FY | 5.84 Million USD | -28.86% |
| 2001 FY | 8.21 Million USD | 3.42% |
| 2001 Q1 | 8.48 Million USD | 6.77% |
| 2001 Q2 | 9.54 Million USD | 12.52% |
| 2001 Q4 | 8.21 Million USD | 0.31% |
| 2001 Q3 | 8.19 Million USD | -14.18% |
| 2000 Q3 | 21.81 Million USD | 2.12% |
| 2000 FY | 7.94 Million USD | -51.56% |
| 2000 Q1 | 20.13 Million USD | 22.76% |
| 2000 Q4 | 7.94 Million USD | -63.58% |
| 2000 Q2 | 21.35 Million USD | 6.09% |
| 1999 Q3 | 14.3 Million USD | 13.49% |
| 1999 Q2 | 12.6 Million USD | 2.44% |
| 1999 Q1 | 12.3 Million USD | 0.0% |
| 1999 FY | 16.4 Million USD | 33.33% |
| 1999 Q4 | 16.4 Million USD | 14.69% |
| 1998 FY | 12.3 Million USD | 66.22% |
| 1998 Q3 | 10.7 Million USD | 16.3% |
| 1998 Q4 | 12.3 Million USD | 14.95% |
| 1998 Q1 | 7.6 Million USD | 2.7% |
| 1998 Q2 | 9.2 Million USD | 21.05% |
| 1997 FY | 7.4 Million USD | -17.78% |
| 1997 Q1 | 6.4 Million USD | -28.89% |
| 1997 Q2 | 6.5 Million USD | 1.56% |
| 1997 Q3 | 4.9 Million USD | -24.62% |
| 1997 Q4 | 7.4 Million USD | 51.02% |
| 1996 Q3 | 9 Million USD | 45.16% |
| 1996 Q1 | 6 Million USD | 15.38% |
| 1996 FY | 9 Million USD | 73.08% |
| 1996 Q4 | 9 Million USD | 0.0% |
| 1996 Q2 | 6.2 Million USD | 3.33% |
| 1995 Q2 | 4.3 Million USD | 48.28% |
| 1995 Q4 | 5.2 Million USD | 26.83% |
| 1995 FY | 5.2 Million USD | 116.67% |
| 1995 Q1 | 2.9 Million USD | 20.83% |
| 1995 Q3 | 4.1 Million USD | -4.65% |
| 1994 Q3 | 1.3 Million USD | -18.75% |
| 1994 Q1 | 1.4 Million USD | -12.5% |
| 1994 Q2 | 1.6 Million USD | 14.29% |
| 1994 FY | 2.4 Million USD | 50.0% |
| 1994 Q4 | 2.4 Million USD | 84.62% |
| 1993 Q2 | 300 Thousand USD | 0.0% |
| 1993 FY | 1.6 Million USD | 166.67% |
| 1993 Q4 | 1.6 Million USD | 433.33% |
| 1993 Q3 | 300 Thousand USD | 0.0% |
| 1992 Q4 | 600 Thousand USD | 0.0% |
| 1992 FY | 600 Thousand USD | -45.45% |
| 1991 Q4 | 1.1 Million USD | 0.0% |
| 1991 Q1 | 2.3 Million USD | -4.17% |
| 1991 FY | 1.1 Million USD | -54.17% |
| 1990 FY | 2.4 Million USD | -79.49% |
| 1990 Q4 | 2.4 Million USD | 0.0% |
| 1989 FY | 11.7 Million USD | 18.18% |
| 1989 Q4 | 11.7 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 58.19% |
| AngioDynamics, Inc. | 5.91 Million USD | -505.918% |
| AtriCure, Inc. | 74.49 Million USD | 51.897% |
| Avinger, Inc. | 15.39 Million USD | -132.764% |
| Azenta, Inc. | 60.43 Million USD | 40.708% |
| BioLife Solutions, Inc. | 42.69 Million USD | 16.062% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 98.605% |
| Daxor Corporation | 755.65 Thousand USD | -4642.086% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -399.916% |
| Femasys Inc. | 6.7 Million USD | -434.765% |
| GlucoTrack, Inc. | 196 Thousand USD | -18182.653% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 16.223% |
| Hologic, Inc. | 2.53 Billion USD | 98.586% |
| ICU Medical, Inc. | 1.7 Billion USD | 97.898% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 60.096% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -706.142% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -87.662% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 96.306% |
| Microbot Medical Inc. | 231 Thousand USD | -15412.554% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -388.792% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 95.98% |
| Nephros, Inc. | 1.83 Million USD | -1851.743% |
| NovoCure Limited | 596.24 Million USD | 93.99% |
| NEXGEL, Inc. | 2.79 Million USD | -1180.701% |
| NEXGEL, Inc. | 2.79 Million USD | -1180.701% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 52.404% |
| OraSure Technologies, Inc. | 13.5 Million USD | -165.358% |
| Pro-Dex, Inc. | 13.54 Million USD | -164.516% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -291.885% |
| Predictive Oncology Inc. | 2.85 Million USD | -1154.334% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -943.366% |
| QuidelOrtho Corporation | 2.61 Billion USD | 98.629% |
| Repligen Corporation | 711.8 Million USD | 94.966% |
| Sanara MedTech Inc. | 11.79 Million USD | -203.881% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -10377.778% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 98.441% |
| Jin Medical International Ltd. | 4.11 Million USD | -771.238% |